Baxter International Inc (BAX)

BAX on New York Consolidated

36.61USD
12 Feb 2016
Change (% chg)

$0.73 (+2.03%)
Prev Close
$35.88
Open
$36.11
Day's High
$36.63
Day's Low
$35.79
Volume
3,560,892
Avg. Vol
5,098,518
52-wk High
$43.44
52-wk Low
$32.18

BAX

Chart for BAX

About

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment, which include three commercial franchises: Hemophilia, BioTherapeutics and BioSurgery, and Medical Products segment, which include four commercial franchises: Fluid Systems, Renal, Specialty... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $20,026.32
Shares Outstanding(Mil.): 547.02
Dividend: 0.12
Yield (%): 1.26

Financials

  BAX Industry Sector
P/E (TTM): 50.27 106.49 37.45
EPS (TTM): 0.73 -- --
ROI: -- 10.55 14.17
ROE: -- 13.06 14.92
Search Stocks

Baxter forecasts current-quarter profit below estimates

Baxter International Inc reported lower quarterly revenue and forecast current-quarter earnings below analysts' estimates, hurt by a strong dollar and rising generic competition for its chemotherapy treatment in the United States.

02 Feb 2016

UPDATE 2-Baxter forecasts current-quarter profit below estimates

* Sees Q1 adj earnings 28-30 cents/shr vs est 31 cents/share (Adds details, shares)

02 Feb 2016

CORRECTED-UPDATE 1-Baxter revenue falls 7 percent hit by dollar

Feb 2 Hospital products and drug maker Baxter International Inc's quarterly revenue fell 7 percent, hurt by a strong dollar and increased generic competition for its chemotherapy treatment in the United States.

02 Feb 2016

Baxter profit falls 78 pct

Feb 2 Baxter International Inc reported a 78 percent fall in quarterly profit, hurt by lower sales of its hospital products.

02 Feb 2016

BRIEF-Eis Eczacibasi Ilac unit Eczacibasi Baxter to terminate production in Ayazaga facility

* Unit Eczacibasi Baxter Hastane Urunleri decides to terminate production in Ayazaga, Istanbul facility until Dec. 31 gradually due to urban transformation project in Ayazaga and Baxter's group's worldwide reorganization plans

22 Jan 2016

Baxter names former Covidien chief José Almeida CEO

Hospital products maker Baxter International said José Almeida, former chief executive of Covidien Plc, will succeed Robert Parkinson as its top executive on Jan. 1.

28 Oct 2015

UPDATE 1-Baxter names former Covidien chief José Almeida CEO

Oct 28 Hospital products maker Baxter International said José Almeida, former chief executive of Covidien Plc, will succeed Robert Parkinson as its top executive on Jan. 1.

28 Oct 2015

Baxter names former Covidien chief José Almeida CEO

Oct 28 Hospital products maker Baxter International said it named José Almeida chief executive officer, succeeding Robert Parkinson, who retires on Jan. 1.

28 Oct 2015

Baxter to cut 1,400 jobs worldwide to boost profits

Baxter International Inc said on Tuesday it plans to cut about 1,400 jobs worldwide, or about 5 percent of its non-manufacturing workforce, as part of a broad effort to reduce costs and boost profits.

27 Oct 2015

Baxter to cut 1,400 jobs worldwide to boost profits

Oct 27 Baxter International Inc said on Tuesday it plans to cut about 1,400 jobs worldwide, or about 5 percent of its non-manufacturing workforce, as part of a broad effort to reduce costs and boost profits.

27 Oct 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : Stock Traders Daily
$20.00
Provider : Stock Traders Daily
$20.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks